Join the club for FREE to access the whole archive and other member benefits.

Felipe Sierra

Director of the Division of Aging Biology at the National Institute on Aging

Biography

Felipe Sierra, PhD. is the Director of the Division of Aging Biology at the National Institute on Aging, NIH. Trained as a biochemist in his native Chile, he obtained a PhD in Biochemistry and Molecular Biology from the University of Florida in 1983. After a postdoc at the University of Geneva, he worked in industry (at Nestlé, still in Switzerland) for the next 5 years. At this stage he developed his interest in the biology of aging, an interest that brought him back to Academia (and to the United States), as an Assistant Professor at the Medical College of Pennsylvania, and later as an Associate Professor at the Lankenau Institute for Medical Research in Pennsylvania. This last position was shared with a primary appointment at the University of Chile in Santiago. Four years after initiating this arrangement, Dr. Sierra relocated again to the US, this time as a Program Director within the Division of Aging Biology, NIA. He became the Director of this unit in April 2006.


Dr. Sierra is also the founder and coordinator of the trans-NIH Geroscience Interest Group (GSIG). The group spans the entire NIH, and is built on the fact that aging is the major risk factor for most chronic age-related diseases – Alzheimer’s, cardiovascular disease, cancer, and more – and thus understanding the basic biology of aging is central to our ability to address these diseases. In 2013 and 2014 he received NIH Director’s Awards for this effort.

Visit website: https://www.nia.nih.gov/about/staff/sierra-luis

 Login to view link, or join the club to get full access to all resources and other benefits.

See also: Institute National Institute on Aging (NIA) - Conducting and supporting research on aging and the health and well-being of older people.

Felipe Sierra News

Comprehensive history and explanation of senescent cells

The Scientist - 01-Mar-2020

Including the latest on clinical trials of first-generation senolytics

Read more...

Living Forever

Proto - 13-Jun-2017

Review of current thinking from the Massachusetts General Hospital - the largest teaching hospita...

Read more...